modafinil has been researched along with Stevens-Johnson Syndrome in 4 studies
Modafinil: A benzhydryl acetamide compound, central nervous system stimulant, and CYP3A4 inducing agent that is used in the treatment of NARCOLEPSY and SLEEP WAKE DISORDERS.
modafinil : A racemate comprising equimolar amounts of armodafinil and (S)-modafinil. A central nervous system stimulant, it is used for the treatment of sleeping disorders such as narcolepsy, obstructive sleep apnoea, and shift-work sleep disorder. The optical enantiomers of modafinil have similar pharmacological actions in animals.
2-[(diphenylmethyl)sulfinyl]acetamide : A sulfoxide that is dimethylsulfoxide in which two hydrogens attached to one of the methyl groups are replaced by phenyl groups, while one hydrogen attached to the other methyl group is replaced by a carbamoyl (aminocarbonyl) group.
Stevens-Johnson Syndrome: Rare cutaneous eruption characterized by extensive KERATINOCYTE apoptosis resulting in skin detachment with mucosal involvement. It is often provoked by the use of drugs (e.g., antibiotics and anticonvulsants) or associated with PNEUMONIA, MYCOPLASMA. It is considered a continuum of Toxic Epidermal Necrolysis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We present the case of a 21-year-old woman in whom Stevens-Johnson syndrome (SJS) developed after initiation of armodafinil." | 7.88 | Stevens-Johnson Syndrome After Armodafinil Use. ( Holfinger, S; Roy, A; Schmidt, M, 2018) |
| "We present the case of a 21-year-old woman in whom Stevens-Johnson syndrome (SJS) developed after initiation of armodafinil." | 3.88 | Stevens-Johnson Syndrome After Armodafinil Use. ( Holfinger, S; Roy, A; Schmidt, M, 2018) |
| "Modafinil is a nonamphetamine nootropic drug with an increasingly therapeutic interest due to its different sites of action and behavioral effects in comparison to cocaine or amphetamine." | 2.66 | Pharmacokinetic and pharmacodynamic of the cognitive enhancer modafinil: Relevant clinical and forensic aspects. ( Dinis-Oliveira, RJ; Sousa, A, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sousa, A | 1 |
| Dinis-Oliveira, RJ | 1 |
| Prince, V | 1 |
| Philippidou, M | 1 |
| Walsh, S | 1 |
| Creamer, D | 1 |
| Holfinger, S | 1 |
| Roy, A | 1 |
| Schmidt, M | 1 |
| Broadbent, K | 1 |
1 review available for modafinil and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Pharmacokinetic and pharmacodynamic of the cognitive enhancer modafinil: Relevant clinical and forensic aspects.
Topics: Anxiety; Diarrhea; Drug Eruptions; Drug Interactions; Erythema Multiforme; Forensic Sciences; Headac | 2020 |
3 other studies available for modafinil and Stevens-Johnson Syndrome
| Article | Year |
|---|---|
Stevens-Johnson syndrome induced by modafinil.
Topics: Adult; Female; Humans; Modafinil; Skin; Stevens-Johnson Syndrome; Wakefulness-Promoting Agents | 2018 |
Stevens-Johnson Syndrome After Armodafinil Use.
Topics: Female; Humans; Idiopathic Hypersomnia; Modafinil; Skin; Stevens-Johnson Syndrome; Wakefulness-Promo | 2018 |
A surprising presentation of blistering mouth ulcers.
Topics: Adult; Benzhydryl Compounds; Blister; Diagnosis, Differential; Humans; Male; Modafinil; Oral Ulcer; | 2016 |